-
Gramine: A Causal Map for Ferroptosis Assays
2026-08-20
Gramine is an indole alkaloid and ferroptosis inducer for investigating the CUL3–MTDH axis in triple-negative breast cancer research. This article translates the latest mechanistic evidence into a causal, orthogonal assay strategy rather than another dose-response guide.
-
Golgi-Tracker Green: Live-Cell Imaging Workflow
2026-08-19
Build reproducible live-cell Golgi apparatus labeling, lipid-trafficking, and sphingolipid metabolism assays with a photostable BODIPY FL-labeled C5-ceramide probe. This guide combines an executable pilot workflow with application-specific controls, troubleshooting, and a careful translation of recent Golgi-fragmentation findings into practical assay design.
-
Macrocyclic Hedgehog Inhibitors: SAR and Mechanism
2026-08-19
Dockendorff and colleagues used a modular build-couple-pair strategy to improve macrocyclic Hedgehog pathway inhibitors and identify analogues with stronger cellular activity than robotnikinin. Their combination of structure–activity studies, Ptch-knockout experiments, and competition with SAG and purmorphamine supports Smoothened antagonism for selected compounds, providing a useful framework for mechanism-focused Hedgehog research.
-
PD 173074: FGFR1 Assay Workflow Guide
2026-08-18
PD 173074 combines structure-informed FGFR1 selectivity with measurable VEGFR2 activity for kinase, cell-signaling, angiogenesis, and cancer research workflows. This guide translates its biochemical profile into practical assay design, dose selection, and troubleshooting strategies.
-
Stattic STAT3 Inhibitor: Practical Research Workflows
2026-08-18
Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with apoptosis induction, radiosensitization, and cancer-cell phenotyping. This guide translates STAT3 biology and microbiome-linked signaling evidence into reproducible workflows, assay controls, and troubleshooting decisions.
-
Resibufogenin and NLRP3 in Atherosclerosis
2026-08-17
A 2025 Journal of Advanced Research study reports that resibufogenin limits atherosclerotic disease in ApoE−/− mice by interfering with NLRP3 inflammasome assembly. Integrating animal, macrophage, molecular docking, and surface plasmon resonance experiments, the work connects CYS-279 binding with reduced inflammation, foam-cell formation, and plaque pathology.
-
GKT137831 at the Redox–Ferroptosis Interface
2026-08-17
GKT137831 offers translational researchers a pharmacological way to interrogate Nox1/Nox4-derived oxidative signaling across vascular, fibrotic, and metabolic disease models. This thought-leadership analysis connects its established redox biology with emerging evidence that plasma-membrane lipid remodeling determines ferroptotic execution—while clearly separating validated findings from forward-looking hypotheses.
-
3-Hydroxybutyrate (BHBA) in Stroke Assays
2026-08-16
Use 3-hydroxybutyrate (BHBA) as a defined ketone-body add-back to dissect ferroptosis, neuronal survival, energy metabolism, and chromatin responses. This workflow separates direct metabolite effects from the broader systemic protection produced by remote ischemic postconditioning.
-
MG-132 Workflow for Proteasome and Apoptosis Studies
2026-08-15
Build more informative apoptosis, cell cycle, and oxidative-stress experiments with MG-132, a cell-permeable proteasome inhibitor that enables timed perturbation of intracellular proteostasis. This guide connects dose optimization and orthogonal readouts with the reference study’s key lesson: biological protection is often strongest when complementary response dimensions are measured together.
-
MG-132: Reliable Cell Viability Assay Workflows
2026-08-14
This scenario-driven guide explains how MG-132, SKU A2585, can improve the interpretation of apoptosis, cell-cycle, viability, and oxidative-stress experiments. It covers concentration selection, solvent handling, orthogonal readouts, and practical criteria for choosing a reliable MG-132 source.
-
ARL4C, Synoviocyte Proliferation, and RA
2026-08-14
This study integrates single-cell and bulk transcriptomic data with cellular perturbation, macrophage co-culture, and collagen-induced arthritis experiments to identify ARL4C as a driver of rheumatoid arthritis progression. Its findings connect ARL4C-dependent fibroblast-like synoviocyte proliferation and invasiveness with macrophage polarization, while suggesting a rationale for measuring S-phase entry during mechanistic and pharmacodynamic studies.
-
Phosbind Acrylamide for Mechanistic Protein Analysis
2026-08-13
Phosbind Acrylamide enables antibody-independent analysis of phosphorylation-dependent mobility shifts in SDS-PAGE. This article shows how to apply the phosphate-binding reagent to mechanistic questions such as the CLK4–NEXN axis in pathological cardiac hypertrophy.
-
5-(N,N-dimethyl)-Amiloride in Endothelial Research
2026-08-13
A translational framework for using 5-(N,N-dimethyl)-Amiloride hydrochloride to connect Na+/H+ exchanger biology, intracellular pH regulation, endothelial injury biomarkers, and cardiac ischemia-reperfusion research while maintaining appropriate mechanistic and experimental limits.
-
Rottlerin: PKCδ Signaling as an Entry Checkpoint
2026-08-12
Rottlerin is a PKC inhibitor that can help dissect how protein kinase C signaling connects cell entry, cytoskeletal remodeling, proliferation, and apoptosis. This article develops a causal assay framework grounded in Spiroplasma infection research rather than repeating conventional apoptosis or protocol guidance.
-
GOB-38 Biochemistry and β-Lactamase Specificity
2026-08-12
The reference study characterized GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, by combining genomic analysis, recombinant expression, enzyme profiling, and bacterial co-culture. Its broad β-lactam substrate range, distinctive active-site residues, and potential role in carbapenem-resistance dissemination clarify why this emerging pathogen is important in β-lactam antibiotic resistance research.